AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
Log in

NASDAQ:TLGTTeligent Stock Price, Forecast & News

$2.30
-0.11 (-4.56 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.18
Now: $2.30
$2.44
50-Day Range
$2.30
MA: $3.17
$4.12
52-Week Range
$1.90
Now: $2.30
$10.90
Volume177,700 shs
Average Volume53,793 shs
Market Capitalization$12.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.94
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. The company is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. Its topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. Teligent, Inc. sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Read More
Teligent logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.80 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.90 million
Book Value($0.99) per share

Profitability

Net Income$-25,120,000.00

Miscellaneous

Employees189
Market Cap$12.39 million
Next Earnings Date8/3/2020 (Estimated)
OptionableOptionable

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.

Teligent (NASDAQ:TLGT) Frequently Asked Questions

How has Teligent's stock been impacted by COVID-19 (Coronavirus)?

Teligent's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TLGT shares have decreased by 29.2% and is now trading at $2.30. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Teligent?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Teligent.

When is Teligent's next earnings date?

Teligent is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Teligent.

How were Teligent's earnings last quarter?

Teligent Inc (NASDAQ:TLGT) posted its quarterly earnings results on Friday, May, 22nd. The company reported ($2.30) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.80) by $0.50. The business had revenue of $7.45 million for the quarter. Teligent had a negative net margin of 71.80% and a negative return on equity of 682.10%. View Teligent's earnings history.

When did Teligent's stock split? How did Teligent's stock split work?

Shares of Teligent reverse split on the morning of Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 27th 2020. An investor that had 100 shares of Teligent stock prior to the reverse split would have 10 shares after the split.

Has Teligent been receiving favorable news coverage?

News articles about TLGT stock have been trending somewhat negative this week, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Teligent earned a coverage optimism score of -1.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news about Teligent.

Are investors shorting Teligent?

Teligent saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 681,200 shares, an increase of 50.9% from the June 15th total of 451,400 shares. Based on an average daily volume of 56,500 shares, the days-to-cover ratio is currently 12.1 days. Approximately 15.6% of the company's shares are short sold. View Teligent's Current Options Chain.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), General Electric (GE), AbbVie (ABBV), Aquinox Pharmaceuticals (AQXP), Selecta Biosciences (SELB), Exxon Mobil (XOM), Akorn (AKRX) and Bausch Health Companies (BHC).

Who are Teligent's key executives?

Teligent's management team includes the following people:
  • Mr. Jason Grenfell-Gardner M.B.A., M.B.A, Pres, CEO & Director (Age 44)
  • Mr. Stephen Richardson, Chief Scientific Officer (Age 53)
  • Mr. Martin Wilson, Gen. Counsel (Age 42)
  • Mr. Damian Finio, Corp. Sec. & CFO (Age 49)
  • Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 50)

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

Who are Teligent's major shareholders?

Teligent's stock is owned by a number of retail and institutional investors. Top institutional investors include Sanders Morris Harris LLC (7.52%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner and Stephen Richardson. View institutional ownership trends for Teligent.

Which institutional investors are selling Teligent stock?

TLGT stock was sold by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC. View insider buying and selling activity for Teligent.

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $2.30.

How big of a company is Teligent?

Teligent has a market capitalization of $12.39 million and generates $65.90 million in revenue each year. Teligent employs 189 workers across the globe.

What is Teligent's official website?

The official website for Teligent is www.teligent.com.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.